TX SB875 | 2021-2022 | 87th Legislature

Status

Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on March 1 2021 - 25% progression, died in committee
Action: 2021-03-23 - Left pending in committee
Pending: Senate Business & Commerce Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Relating to prescription drug price disclosure; authorizing a fee; providing an administrative penalty.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relating to prescription drug price disclosure; authorizing a fee; providing an administrative penalty.

Sponsors


History

DateChamberAction
2021-03-23SenateLeft pending in committee
2021-03-23SenateConsidered in public hearing
2021-03-23SenateScheduled for public hearing on . . .
2021-03-11SenateReferred to Business & Commerce
2021-03-11SenateRead first time
2021-03-01SenateFiled
2021-03-01SenateReceived by the Secretary of the Senate

Same As/Similar To

HB1033 (Same As) 2021-05-18 - Effective on 9/1/21

Subjects


Texas State Sources


Bill Comments

feedback